Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas

Radiotherapy and Oncology

Volumn 60, Issue 2, 2001, Pages 137-145

  Muriel, Vicente Pedraza ^a   Tejada, María Rosario Guerrero ^a   De Dios Luna Del Castillo, Juan ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Head and neck carcinoma; Postoperative radiotherapy; Prognostic factors; Radiation dose; Time interval; Total treatment time; Tumour control

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR CELL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROBABILITY; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 0034951407     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00381-4     Document Type: Article

References (57)

1. Postoperative irradiation for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications
2. Altered fractionation trials in head and neck cancer
3. Overall time factor in postoperative radiation: Results of a prospective randomised trial
4. Overall time factor in postoperative radiation: Results of a prospective randomised trial
5. Management of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx
6. The value of postoperative radiotherapy as an adjuvant to radical neck dissection
7. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer
8. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors
9. Clinical evidence for tumor clonogen repopulation: Interpretations of the data
10. Clinical radiobiology of squamous cell carcinoma of the oropharynx
11. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma
12. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinoma of the oral cavity or oropharynx
13. Clinical dose response curve of subclinical aggregates of epithelial cells and its practical application in the management of human cancers
14. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer
15. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation therapy for head and neck squamous carcinomas: First report of the RTOG 9003
16. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumour proliferation
17. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancer: Results of the EORTC 22851 randomized trial
18. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margin: A comparative study
19. The extracapsular spread of tumors in cervical node metastases
20. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of the study 73-03 of the Radiation Therapy Oncology Group
21. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck? A comparative study using the Intergroup Study 0034 and the Radiation Therapy Oncology Group head and neck database
22. The impact of local tumor control on the outcome of human cancer
23. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck data base
24. The significance of positive margins in marginally resected epidermoid carcinoma
25. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: A matched pair analysis
26. Planned combination of surgery and radiation in the treatment of advanced primary head and neck cancer
27. Dose fractionation and regeneration for cancer of the oral cavity and oropharynx: Tumor-dose response and repopulation
28. Postoperative radiotherapy for persistent tumor at the surgical margin in head and neck cancer
29. Postoperative irradiation for squamous cell carcinomas of the head and neck: Analysis of time-dose factors related to control above the clavicles
30. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas
31. Advanced carcinoma of the larynx: Results of surgery and radiotherapy without induction chemotherapy (1980-1985): A multivariate analysis
32. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
33. A reevaluation of split course technique for squamous cell carcinoma of the head and neck
34. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity
35. The efficacy of postoperative radiotherapy for advanced head and neck cancer: Quality of evidence
36. Applying radiobiological principles to combined modality treatment for head and neck cancer. The time factor
37. Altered fractionation schedules
38. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial
39. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract
40. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy?
41. Carcinoma of the oral cavity: Factors affecting treatment failure at the primary site and the neck
42. The potential benefit from individualised radiotherapy scheduling for head and neck tumours on the basis of both histological grade and kinetics
43. pot
44. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation
45. What is known about tumour proliferation rates to choose between accelerated fractionation and hyperfractionation
46. Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumors and normal tissues
47. Repopulation in human tumours
48. The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and lower supraglottic
49. Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx
50. Failure at the primary site following multimodality treatment for advanced head and neck cancer
51. Failure in the neck following multimodality treatment for advanced head and neck cancer
52. Transmutability of dose and time. Commentary on the first report of RTOG 9003
53. The hazard of accelerated tumor clonogen repopulation during radiotherapy
54. Local control of carcinoma of tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions
55. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with laryngeal cancer